Xu Zhang-Xu
No 69 Yongding Road
Yongding, 100039, China
Yongding, 100039, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Adjuvant penpulimab in very-high risk clear cell renal cell carcinoma: a prospective, non-randomized, controlled phase II trial with integrated plasma multi-omics analyses.
Journal: Journal for immunotherapy of cancer
Published: June 22, 2026
Kidney‑enriched lipid nanoparticles delivering ANXA2 alleviate renal ischemia-reperfusion injury via CHMP2A-mediated necroptosis inhibition.
Journal: Journal of nanobiotechnology
Published: March 06, 2026
APR-246 drives ROS-dependent ferroptosis and apoptosis and enhances anti-PD-1 efficacy in bladder cancer.
Journal: Scientific reports
Published: February 03, 2026
Real-World Evidence on Preoperative Targeted Therapy for Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus.
Journal: Clinical genitourinary cancer
Published: December 15, 2025
c-Fos-driven metabolic switch of α-ketoglutarate orchestrates progression in prostate cancer.
Journal: Cell death & disease
Published: December 12, 2025
Incidence and risk factors of LUTS associated with benign prostatic hyperplasia among Chinese men: findings from the CHARLS cohort.
Journal: Scientific reports
Published: August 25, 2025
ASO Author Reflections: Is Congestive Renal Injury Caused by Inferior Vena Cava Tumor Thrombus Reversible?
Journal: Annals of surgical oncology
Published: July 25, 2025
DR5/WDR12 balances p65 stability promoting sunitinib resistance in renal cell carcinoma.
Journal: Cell death and differentiation
Published: May 07, 2025
Last Updated: 09/26/2026